NCT07187921Completed
Evaluation of a Finger Prick Collection Method for Measuring Alzheimer's Disease Blood Biomarkers
Evaluation of a Finger Prick Collection Method for Measuring Alzheimer's Disease Blood Biomarkers (eDROP-AD)
Source: ClinicalTrials.gov · Last updated 9 Dec 2025
Brief summary (registry, in English)
This is an observational study that will collect blood from a finger prick (Capitainer SEP10 single channel device) and assess the accuracy of pTau-217 testing in comparison to previously collected venous blood samples from the same individuals.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 49 (actual)
- First submitted
- 11 Sept 2025
- Start date
- 29 Sept 2025
- Primary completion date
- 12 Nov 2025
- Lead sponsor
- Banner Health
- Diseases
- Alzheimer disease
- NCT number
- NCT07187921
What you commit to
- Study type: Observational
- Participants enrolled: 49
- From 29 Sept 2025 to the primary completion date, 12 Nov 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- \-
Who the study is looking for
- Able and willing to provide informed consent for the eDROP-AD study.
- Enrolled in the Draw-10 study at Banner Alzheimer's Institute-Phoenix and provided at least one venous blood sample.
- Able and willing to fully comply with study procedures defined in this protocol.
- Written and spoken fluency in the English language.
Age in the registry: 50 years to 80 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Banner Alzheimer's Institute Coordinator of this site? Confirm its status | Phoenix | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.